Related Experiment Videos
Curcumin: potential for hepatic fibrosis therapy?
1School of Chemical Sciences and Pharmacy, University of East Anglia, Norwich, UK. m.oconnell@uea.ac.uk
British Journal of Pharmacology
|November 27, 2007
Summary
Curcumin, a compound with anti-inflammatory properties, shows promise in treating liver fibrosis. It inhibits the proliferation and promotes apoptosis in hepatic stellate cells, crucial in liver scarring.
Area of Science:
- Biochemistry
- Hepatology
- Pharmacology
Background:
- Curcumin exhibits antioxidative, anti-inflammatory, and antitumorigenic effects.
- Emerging evidence suggests curcumin's therapeutic potential in chronic liver disease.
- Hepatic fibrosis, characterized by extracellular matrix deposition, can lead to cirrhosis.
Purpose of the Study:
- To investigate the therapeutic potential of curcumin in hepatic fibrosis.
- To elucidate the mechanisms by which curcumin affects hepatic stellate cells (HSCs).
Main Methods:
- Rodent model of liver cirrhosis.
- In vitro studies on hepatic stellate cells (HSCs).
- Analysis of extracellular matrix formation, apoptosis, and proliferation markers.
Main Results:
- Curcumin inhibited liver cirrhosis in a rodent model.
- Curcumin suppressed proliferation and induced apoptosis in HSCs.
- Curcumin modulated extracellular matrix formation by regulating matrix metalloproteinase and connective tissue growth factor (CTGF) expression, involving pathways like ERK and NF-kappaB.
Conclusions:
- Curcumin demonstrates significant potential as a therapeutic agent for hepatic fibrosis.
- Curcumin exerts its effects by modulating multiple intracellular signaling pathways in HSCs.
- Further research into curcumin's role in liver disease therapy is warranted.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...